Balyasny Asset Management’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-190,272
| Closed | -$3.41M | – | 2483 |
|
|
2025
Q1 | $3.41M | Buy |
+190,272
| New | +$3.41M | 0.01% | 979 |
|
|
2024
Q4 | – | Sell |
-1,285,379
| Closed | -$18M | – | 2389 |
|
|
2024
Q3 | $18M | Buy |
+1,285,379
| New | +$18M | 0.03% | 489 |
|
|
2023
Q3 | – | Sell |
-326,570
| Closed | -$5.02M | – | 2222 |
|
|
2023
Q2 | $5.02M | Buy |
+326,570
| New | +$5.02M | 0.01% | 775 |
|
|
2023
Q1 | – | Sell |
-67,349
| Closed | -$1.42M | – | 2661 |
|
|
2022
Q4 | $1.42M | Sell |
67,349
-344,269
| -84% | -$7.24M | ﹤0.01% | 1169 |
|
|
2022
Q3 | $10.1M | Buy |
411,618
+110,412
| +37% | +$2.72M | 0.03% | 545 |
|
|
2022
Q2 | $7.3M | Buy |
+301,206
| New | +$7.3M | 0.02% | 641 |
|
|
2019
Q2 | – | Sell |
-20,534
| Closed | -$465K | – | 1562 |
|
|
2019
Q1 | $465K | Buy |
20,534
+10,613
| +107% | +$240K | ﹤0.01% | 1119 |
|
|
2018
Q4 | $225K | Buy |
+9,921
| New | +$225K | ﹤0.01% | 1182 |
|
|
2017
Q2 | – | Sell |
-109,072
| Closed | -$2.01M | – | 1506 |
|
|
2017
Q1 | $2.01M | Buy |
+109,072
| New | +$2.01M | 0.01% | 756 |
|
|
2016
Q4 | – | Sell |
-45,000
| Closed | -$1.01M | – | 1284 |
|
|
2016
Q3 | $1.01M | Buy |
+45,000
| New | +$1.01M | 0.01% | 674 |
|
|
2015
Q4 | – | Sell |
-18,950
| Closed | -$384K | – | 1293 |
|
|
2015
Q3 | $384K | Buy |
+18,950
| New | +$384K | ﹤0.01% | 691 |
|